Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk-Reducing Surgeries of Salpingo-oophorectomy With/Without Hysterectomy for Carriers With Mutation Genes of Hereditary Ovarian Cancer

NCT03294343 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT03294343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03294343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk-Reducing Surgeries of Salpingo-oophorectomy With/Without Hysterectomy for Carriers With Mutation Genes of Hereditary Ovarian Cancer
Lead sponsor
Lei Li
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2017
Completion date
September 1, 2023
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms, hereditary nonpolyposis, hereditary breast and ovarian cancer syndrome, hysterectomy, ovariectomy